Literature DB >> 26829209

Association Between Three SNPs and Thromboangiitis Obliterans in Xinjiang Uyghur Population.

Zhen-Feng Shi1,2, Qing-Bo Fang2, Sai Limu2, Tang Jiareke2, Xiao-Hu Ge2.   

Abstract

BACKGROUND: Thromboangiitis obliterans (TAO), also called Buerger's disease, is a chronic peripheral vascular occlusive disease. It is an obliterative vasculitis characterized by arterial thrombosis and strongly associated with tobacco exposure. The pathogenesis and etiology of TAO are not well understood, but genetic factors may be important in its development. A case-control study was undertaken to identify genetic factors potentially involved in the pathogenesis of TAO in a Xinjiang Uyghur population of China, where TAO is common.
METHODS: We ascertained 177 TAO patients by clinical screening and 86 healthy individuals from the HAPMAP database. The genotypes of single-nucleotide polymorphisms (SNPs) of the participants were identified using the Affymetrix Genome-Wide Human SNP Array 6.0 to perform a genome wide association study (GWAS). The association between the SNPs and incidence of TAO was quantified using race stratification exposure.
RESULTS: Through a case-control GWAS study 26 SNPs were significantly associated with incidence of TAO following a Bonferroni correction. However, after genomic control correction for population stratification only three of these SNPS were highly significantly associated with TAO: rs376511 in IL17RC (OR = 24.4, 95% CI:8.68 - 68.62, p < 0.0001), rs7632505 in SEMA5B (OR = 29.47, 95% CI:7.16 - 121.3, p < 0.0001), and rs10178082 (OR = 18.09, 95% CI: 6.56 - 49.92, p < 0.0001) showed a significant risk of TAO in the Uyghur population.
CONCLUSIONS: This study shows an association between these 3 SNPs and susceptibility to TAO in the Uyghur population, suggesting that polymorphisms in the IL-17RC and Sema 5B genes may pre-dispose individuals in this population to development of TAO. These findings require replication.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26829209      PMCID: PMC4761799          DOI: 10.1089/gtmb.2015.0264

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  30 in total

1.  Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

Authors:  T Nagase; R Kikuno; K Ishikawa; M Hirosawa; O Ohara
Journal:  DNA Res       Date:  2000-04-28       Impact factor: 4.458

Review 2.  Thromboangiitis obliterans (Buerger's disease).

Authors:  J W Olin
Journal:  N Engl J Med       Date:  2000-09-21       Impact factor: 91.245

3.  Association of HLA-A9 and HLA-B5 with Buerger's disease.

Authors:  G A McLoughlin; C R Helsby; C C Evans; D M Chapman
Journal:  Br Med J       Date:  1976-11-13

4.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

5.  Transmembrane semaphorin5B is proteolytically processed into a repulsive neural guidance cue.

Authors:  Kristen Browne; Wenyan Wang; Rachel Q Liu; Matthew Piva; Timothy P O'Connor
Journal:  J Neurochem       Date:  2012-08-14       Impact factor: 5.372

Review 6.  The cell biology of thrombospondin-1.

Authors:  H Chen; M E Herndon; J Lawler
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

7.  Autoimmunological aspects of thromboangiitis obliterans (Buerger's disease).

Authors:  J S Smolen; U Youngchaiyud; P Weidinger; M Kojer; A T Endler; W R Mayr; E J Menzel
Journal:  Clin Immunol Immunopathol       Date:  1978-10

8.  Natural history of Buerger's disease.

Authors:  J Nielubowicz; A Rosnowski; B Pruszynski; Z Przetakiewicz; A Potemkowski
Journal:  J Cardiovasc Surg (Torino)       Date:  1980 Sep-Oct       Impact factor: 1.888

Review 9.  Interleukin-17 family members and inflammation.

Authors:  Jay K Kolls; Anders Lindén
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

10.  Semaphorin-3F is an inhibitor of tumor angiogenesis.

Authors:  Ofra Kessler; Niva Shraga-Heled; Tali Lange; Noga Gutmann-Raviv; Edmond Sabo; Limor Baruch; Marcelle Machluf; Gera Neufeld
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

View more
  3 in total

Review 1.  Peripheral Arterial Disease Genetics: Progress to Date and Challenges Ahead.

Authors:  Nathan Belkin; Scott M Damrauer
Journal:  Curr Cardiol Rep       Date:  2017-11-01       Impact factor: 2.931

2.  An Enrichment Strategy Yields Seven Novel Single Nucleotide Polymorphisms Associated With Mortality and Altered Th17 Responses Following Blunt Trauma.

Authors:  Lukas Schimunek; Rami A Namas; Jinling Yin; Dongmei Liu; Derek Barclay; Fayten El-Dehaibi; Andrew Abboud; Haley Lindberg; Ruben Zamora; Timothy R Billiar; Yoram Vodovotz
Journal:  Shock       Date:  2018-03       Impact factor: 3.454

3.  Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.

Authors:  Liang He; Yelena Kernogitski; Irina Kulminskaya; Yury Loika; Konstantin G Arbeev; Elena Loiko; Olivia Bagley; Matt Duan; Arseniy Yashkin; Svetlana V Ukraintseva; Mikhail Kovtun; Anatoliy I Yashin; Alexander M Kulminski
Journal:  Front Genet       Date:  2016-10-13       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.